82P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pacira Biosciences Inc

Watchlist Manager

Watchlist

Price: 21 EUR -2.78%

Market Cap: €1.8B

P	Pacira Biosciences Inc SWB:82P	US
K	Kinder Morgan Inc SWB:2KD	US
	Vivoryon Therapeutics NV F:05Y	DE
M	Matador Resources Co F:7MR	US
A	Axon Enterprise Inc DUS:TCS	US
	Basf Se MIL:1BAS	DE

Profitability Summary

Pacira Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

75%

Gross Margin is Increasing

69% > 79%

Low Operating Margin

Sustainable 3Y Average Operating Margin

11%

Declining Operating Margin

10% > 5%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-1% > 1%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

20%

Declining Free Cash Flow Margin

19% > 18%

Low ROE

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.